Home/Filings/4/0001209191-16-102151
4//SEC Filing

FIBROGEN INC 4

Accession 0001209191-16-102151

$FGENCIK 0000921299operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:20 PM ET

Size

7.6 KB

Accession

0001209191-16-102151

Insider Transaction Report

Form 4
Period: 2016-02-22
VALONE FRANK H MD
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2016-02-22+11,765108,605 total
  • Award

    Stock Option (Right to Buy)

    2016-02-22+20,00020,000 total
    Exercise: $19.39Exp: 2026-02-22Common Stock (20,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    4,000
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest over time.
  • [F2]Twenty-five percent of the shares subject to the option vest on March 1, 2017, and the remainder vests in equal amounts quarterly thereafter for the following three years.

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000921299

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:20 PM ET
Size
7.6 KB